The Host Cell Protein (HCP) testing market has been steadily growing, driven by advancements in biopharmaceutical manufacturing and the increasing demand for effective quality control measures. According to recent market research, the HCP testing market size was valued at USD 1.26 billion in 2022 and is projected to reach USD 1.99 billion by 2030, with a compound annual growth rate (CAGR) of...

The Toxoid Vaccine Market size was worth US$ 5.61 billion in 2022 and is estimated to reach US$ 8.22 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2023-2030. Several key factors are propelling this market growth: Rising Immunization Rates: Increased emphasis on global vaccination programs, particularly in developing countries, drives demand for...